Shares of Dabur India rose 3.5% after the results were declared, as against 0.37% gain in the benchmark Nifty 50.

Resisting Dabur India's fresh injunction application alleging disparaging of its products by Patanjali Ayurveda, the Ramdev ...

Patanjali faces multiple legal and regulatory challenges, from FSSAI recalls to misleading health claims and lawsuits from ...

Patanjali insists it didn’t name Dabur or directly compare products, arguing the claims ... For a sector like Ayurveda, which relies heavily on consumer faith in traditional remedies, the ...

The sector plays a crucial role in the Indian economy, providing employment to around 3 million people and accounting for ...

The global ayurvedic supplement market is on a trajectory of extraordinary expansion, with industry experts predicting a ...

Dabur India today approved the financial results (Standalone and Consolidated) for the third quarter and nine months of ...

Unlike artificial supplements, Ayurvedic products boost health naturally, ensuring long-term benefits without unwanted side effects," he explained. Ashwagandha, according to the doctor ...

Despite the recent rise in herbal supplement use, research suggests certain supplements may pose risks for patients with autoimmune diseases.

Rooted in Ayurverdic medicine, Kin Euphorics is exploring the world of functional ingredients to push the boundaries of the ...